Home > Insider Trading > Filing (0001179110-20-010900)

Filing Details

Accession Number:: 0001179110-20-010900
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-06 18:28:01
Reporting Period:: 2020-11-04

Accepted Time:: 2020-11-06 18:28:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711968	Leonard Steven Chapman	C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-11-04	2,188	$9.59	39,088	No	4	M	Direct
Common Stock	Acquisiton	2020-11-04	4,468	$10.41	43,556	No	4	M	Direct
Common Stock	Acquisiton	2020-11-04	2,083	$10.73	45,639	No	4	M	Direct
Common Stock	Acquisiton	2020-11-04	6,105	$9.29	51,744	No	4	M	Direct
Common Stock	Acquisiton	2020-11-04	3,125	$13.01	54,869	No	4	M	Direct
Common Stock	Acquisiton	2020-11-04	13,541	$20.27	68,410	No	4	M	Direct
Common Stock	Disposition	2020-11-04	36,115	$75.00	32,295	No	4	S	Direct
Common Stock	Acquisiton	2020-11-04	20,312	$13.01	52,607	No	4	M	Direct
Common Stock	Disposition	2020-11-04	25,236	$75.00	27,371	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-11-04	2,188	$0.00	2,188	$9.59
Common Stock	Stock Option (right to buy)	Disposition	2020-11-04	4,468	$0.00	4,468	$10.41
Common Stock	Stock Option (right to buy)	Disposition	2020-11-04	2,083	$0.00	2,083	$10.73
Common Stock	Stock Option (right to buy)	Disposition	2020-11-04	6,105	$0.00	6,105	$9.29
Common Stock	Stock Option (right to buy)	Disposition	2020-11-04	3,125	$0.00	3,125	$13.01
Common Stock	Stock Option (right to buy)	Disposition	2020-11-04	13,541	$0.00	13,541	$20.27
Common Stock	Stock Option (right to buy)	Disposition	2020-11-04	20,312	$0.00	20,312	$13.01

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2026-04-07	No	4	M	Direct
23,461	2027-06-08	No	4	M	Direct
10,417	2027-07-13	No	4	M	Direct
67,156	2028-03-08	No	4	M	Direct
66,666	2029-01-10	No	4	M	Direct
71,875	2029-04-11	No	4	M	Direct
81,250	2020-01-10	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2019 as amended on February 28, 2020. The Reporting Person is subject to a Lock-up Letter Agreement that expires on November 10, 2020. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
The option shares vest over four years. 25% of the option shares vested and became exercisable on April 1, 2017 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of June 23, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.